Xbiotech, Inc.
Clinical trials sponsored by Xbiotech, Inc., explained in plain language.
-
New combo therapy aims to tame rheumatoid arthritis
Disease control Not yet recruitingThis study tests whether adding a new drug, natrunix, to the standard treatment methotrexate helps control moderate to severe rheumatoid arthritis better than methotrexate alone. About 108 adults who have not responded well enough to methotrexate will receive weekly injections fo…
Phase: PHASE2 • Sponsor: XBiotech, Inc. • Aim: Disease control
Last updated May 17, 2026 08:51 UTC
-
New drug combo aims to ease back pain in genetic arthritis
Disease control Not yet recruitingThis study tests a new drug called Natrunix, given with standard care, for people with a type of arthritis that affects the spine and joints (axial spondyloarthritis). The trial includes 60 adults who have a specific genetic marker (HLA-B27) and active disease. The goal is to see…
Phase: PHASE2 • Sponsor: XBiotech, Inc. • Aim: Disease control
Last updated May 11, 2026 20:48 UTC